Sep 19 2012
Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. 
      (OTCBB: RBCC), announced today that it is exploring the possible use of 
      micro-gravity technology developed by NASA to produce three-dimensional 
      adult stem cells for medical research purposes.
    
    
      RBCC announced on Monday that it will expand its focus on technology 
      capable of culturing 3D cell clusters to include adult stem cells. The 
      company is currently investigating the potential for a bioreactor 
      developed for the space program to grow tissues from adult stem cells 
      for possible study and even transplantation. Stem cells grown using the 
      NASA technology multiply rapidly and remain three dimensional, unlike 
      the two-dimensional cells grown in Petri dishes.
    
    
      This characteristic makes possible the production of healthy populations 
      of cheaper and higher-quality stem cells suitable for all manner of 
      research.
    
    
      "This technology has the potential to be one of NASA's greatest gifts to 
      medical sciences," said RBCC CEO Patrick Brown. "The ability to 
      cultivate adult stem cells in a micro-gravity environment here on earth 
      could prove to be a great leap forward in the field of biotechnology, 
      and we're very interested in discussing how we might be able to assist 
      in the development and marketing of new therapies and other uses for 
      this device."
    
    Source: Rainbow BioSciences